{{Rsnum
|rsid=837841
|Chromosome=2
|position=129276439
|Orientation=minus
|GMAF=0.4885
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 34.8 | 45.5 | 19.6
| HCB | 9.3 | 39.5 | 51.2
| JPT | 18.2 | 35.5 | 46.4
| YRI | 23.8 | 51.7 | 24.5
| ASW | 26.3 | 56.1 | 17.5
| CHB | 9.3 | 39.5 | 51.2
| CHD | 23.8 | 42.9 | 33.3
| GIH | 40.8 | 44.9 | 14.3
| LWK | 35.5 | 47.3 | 17.3
| MEX | 13.8 | 37.9 | 48.3
| MKK | 28.9 | 52.6 | 18.4
| TSI | 42.2 | 46.1 | 11.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=8E-6
  |OR=1.28
  |ORtxt=[0.930-1.759]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}